Patents by Inventor Yves Théorêt

Yves Théorêt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120196878
    Abstract: The present invention provides a method of optimizing therapeutic efficacy and reducing toxicity associated with 6-mercaptopurine drug treatment of an immune-mediated gastrointestinal disorder such as inflammatory bowel disease. The method of the invention includes the step of determining the level of one or more 6-mercaptopurine metabolites in the patient having an immune-mediated gastrointestinal disorder.
    Type: Application
    Filed: August 30, 2011
    Publication date: August 2, 2012
    Applicant: Hôpital-Sainte-Justine
    Inventors: Ernest G. Seidman, Yves Théorêt
  • Patent number: 8030293
    Abstract: The present invention provides a method of optimizing therapeutic efficacy and reducing toxicity associated with 6-mercaptopurine drug treatment of an immune-mediated gastrointestinal disorder such as inflammatory bowel disease. The method of the invention includes the step of determining the level of one or more 6-mercaptopurine metabolites in the patient having an immune-mediated gastrointestinal disorder.
    Type: Grant
    Filed: August 4, 2009
    Date of Patent: October 4, 2011
    Assignee: Hopital-Sainte-Justine
    Inventors: Ernest G. Seidman, Yves Theoret
  • Publication number: 20100029692
    Abstract: The present invention provides a method of optimizing therapeutic efficacy and reducing toxicity associated with 6-mercaptopurine drug treatment of an immune-mediated gastrointestinal disorder such as inflammatory bowel disease. The method of the invention includes the step of determining the level of one or more 6-mercaptopurine metabolites in the patient having an immune-mediated gastrointestinal disorder.
    Type: Application
    Filed: August 4, 2009
    Publication date: February 4, 2010
    Applicant: Hopital-Sainte-Justine
    Inventors: Ernest G. Seidman, Yves Théorêt
  • Patent number: 7625876
    Abstract: The present invention provides a method of optimizing therapeutic efficacy and reducing toxicity associated with 6-mercaptopurine drug treatment of an immune-mediated gastrointestinal disorder such as inflammatory bowel disease. The method of the invention includes the step of determining the level of one or more 6-mercaptopurine metabolites in the patient having an immune-mediated gastrointestinal disorder.
    Type: Grant
    Filed: August 20, 2007
    Date of Patent: December 1, 2009
    Assignee: Hopital-Sainte-Justine
    Inventors: Ernest G. Seidman, Yves Theoret
  • Patent number: 7429570
    Abstract: The present invention provides a method of optimizing therapeutic efficacy and reducing toxicity associated with 6-mercaptopurine drug treatment of an immune-mediated gastrointestinal disorder such as inflammatory bowel disease. The method of the invention includes the step of determining the level of one or more 6-mercaptopurine metabolites in the patient having an immune-mediated gastrointestinal disorder.
    Type: Grant
    Filed: March 21, 2007
    Date of Patent: September 30, 2008
    Assignee: Hopital Sainte-Justine
    Inventors: Ernest G. Seidman, Yves Theoret
  • Patent number: 7425546
    Abstract: The present invention provides a method of optimizing therapeutic efficacy and reducing toxicity associated with 6-mercaptopurine drug treatment of an immune-mediated gastrointestinal disorder such as inflammatory bowel disease. The method of the invention includes the step of determining the level of one or more 6-mercaptopurine metabolites in the patient having an immune-mediated gastrointestinal disorder.
    Type: Grant
    Filed: March 22, 2007
    Date of Patent: September 16, 2008
    Assignee: Hopital Sainte-Justine
    Inventors: Ernest G. Seidman, Yves Theoret
  • Publication number: 20080166750
    Abstract: The present invention provides a method of optimizing therapeutic efficacy and reducing toxicity associated with 6-mercaptopurine drug treatment of an immune-mediated gastrointestinal disorder such as inflammatory bowel disease. The method of the invention includes the step of determining the level of one or more 6-mercaptopurine metabolites in the patient having an immune-mediated gastrointestinal disorder.
    Type: Application
    Filed: August 20, 2007
    Publication date: July 10, 2008
    Applicant: Hopital Sainte-Justine
    Inventors: Ernest G. Seidman, Yves Theoret
  • Patent number: 7326694
    Abstract: The present invention provides a method of optimizing therapeutic efficacy and reducing toxicity associated with 6-mercaptopurine drug treatment of an immune-mediated gastrointestinal disorder such as inflammatory bowel disease. The method of the invention includes the step of determining the level of one or more 6-mercaptopurine metabolites in the patient having an immune-mediated gastrointestinal disorder.
    Type: Grant
    Filed: May 26, 2006
    Date of Patent: February 5, 2008
    Assignee: Hopital Sainte-Justine
    Inventors: Ernest G. Seidman, Yves Theoret
  • Publication number: 20070197461
    Abstract: The present invention provides a method of optimizing therapeutic efficacy and reducing toxicity associated with 6-mercaptopurine drug treatment of an immune-mediated gastrointestinal disorder such as inflammatory bowel disease. The method of the invention includes the step of determining the level of one or more 6-mercaptopurine metabolites in the patient having an immune-mediated gastrointestinal disorder.
    Type: Application
    Filed: March 21, 2007
    Publication date: August 23, 2007
    Applicant: Hopital Sainte-Justine
    Inventors: Ernest Seidman, Yves Theoret
  • Publication number: 20070197554
    Abstract: The present invention provides a method of optimizing therapeutic efficacy and reducing toxicity associated with 6-mercaptopurine drug treatment of an immune-mediated gastrointestinal disorder such as inflammatory bowel disease. The method of the invention includes the step of determining the level of one or more 6-mercaptopurine metabolites in the patient having an immune-mediated gastrointestinal disorder.
    Type: Application
    Filed: March 22, 2007
    Publication date: August 23, 2007
    Applicant: Hopital Sainte-Justine
    Inventors: Ernest Seidman, Yves Theoret
  • Publication number: 20060205084
    Abstract: The present invention provides a method of optimizing therapeutic efficacy and reducing toxicity associated with 6-mercaptopurine drug treatment of an immune-mediated gastrointestinal disorder such as inflammatory bowel disease. The method of the invention includes the step of determining the level of one or more 6-mercaptopurine metabolites in the patient having an immune-mediated gastrointestinal disorder.
    Type: Application
    Filed: May 26, 2006
    Publication date: September 14, 2006
    Applicant: Hôpital Sainte-Justine
    Inventors: Ernest Seidman, Yves Theoret
  • Patent number: 7105497
    Abstract: The present invention provides a method of optimizing therapeutic efficacy and reducing toxicity associated with 6-mercaptopurine drug treatment of an immune-mediated gastrointestinal disorder such as inflammatory bowel disease. The method of the invention includes the step of determining the level of one or more 6-mercaptopurine metabolites in the patient having an immune-mediated gastrointestinal disorder.
    Type: Grant
    Filed: June 14, 2005
    Date of Patent: September 12, 2006
    Assignee: Hôpital Sainte-Justine
    Inventors: Ernest G. Seidman, Yves Theoret
  • Patent number: 6987097
    Abstract: The present invention provides a method of optimizing therapeutic efficacy and reducing toxicity associated with 6-mercaptopurine drug treatment of an immune-mediated gastrointestinal disorder such as inflammatory bowel disease. The method of the invention includes the step of determining the level of one or more 6-mercaptopurine metabolites in the patient having an immune-mediated gastrointestinal disorder.
    Type: Grant
    Filed: November 6, 2003
    Date of Patent: January 17, 2006
    Assignee: Hospital Sainte-Justine
    Inventors: Ernest G. Seidman, Yves Théorêt
  • Publication number: 20050234078
    Abstract: The present invention provides a method of optimizing therapeutic efficacy and reducing toxicity associated with 6-mercaptopurine drug treatment of an immune-mediated gastrointestinal disorder such as inflammatory bowel disease. The method of the invention includes the step of determining the level of one or more 6-mercaptopurine metabolites in the patient having an immune-mediated gastrointestinal disorder.
    Type: Application
    Filed: June 14, 2005
    Publication date: October 20, 2005
    Applicant: Hopital Sainte-Justine
    Inventors: Ernest Seidman, Yves Theoret
  • Publication number: 20040097527
    Abstract: The present invention provides a method of optimizing therapeutic efficacy and reducing toxicity associated with 6-mercaptopurine drug treatment of an immune-mediated gastrointestinal disorder such as inflammatory bowel disease. The method of the invention includes the step of determining the level of one or more 6-mercaptopurine metabolites in the patient having an immune-mediated gastrointestinal disorder.
    Type: Application
    Filed: November 6, 2003
    Publication date: May 20, 2004
    Applicant: HOPITAL SAINTE-JUSTINE
    Inventors: Ernest G. Seidman, Yves Theoret
  • Patent number: 6680302
    Abstract: The present invention provides a method of optimizing therapeutic efficacy and reducing toxicity associated with 6-mercaptopurine drug treatment of an immune-mediated gastrointestinal disorder such as inflammatory bowel disease. The method of the invention includes the step of determining the level of one or more 6-mercaptopurine metabolites in the patient having an immune-mediated gastrointestinal disorder.
    Type: Grant
    Filed: December 27, 2001
    Date of Patent: January 20, 2004
    Assignee: Hospital Sainte-Justine
    Inventors: Ernest G. Seidman, Yves Théorêt
  • Publication number: 20020082239
    Abstract: The present invention provides a method of optimizing therapeutic efficacy and reducing toxicity associated with 6-mercaptopurine drug treatment of an immune-mediated gastrointestinal disorder such as inflammatory bowel disease. The method of the invention includes the step of determining the level of one or more 6-mercaptopurine metabolites in the patient having an immune-mediated gastrointestinal disorder.
    Type: Application
    Filed: December 27, 2001
    Publication date: June 27, 2002
    Inventors: Ernest G. Seidman, Yves Theoret
  • Patent number: 6355623
    Abstract: The present invention provides a method of optimizing therapeutic efficacy and reducing toxicity associated with 6-mercaptopurine drug treatment of an immune-mediated gastrointestinal disorder such as inflammatory bowel disease. The method of the invention includes the step of determining the level of one or more 6-mercaptopurine metabolites in the patient having an immune-mediated gastrointestinal disorder.
    Type: Grant
    Filed: April 8, 1999
    Date of Patent: March 12, 2002
    Assignee: Hopital-Sainte-Justine
    Inventors: Ernest G. Seidman, Yves Théorêt
  • Publication number: 20010006970
    Abstract: The present invention provides a method of optimizing therapeutic efficacy and reducing toxicity associated with 6-mercaptopurine drug treatment of an immune-mediated gastrointestinal disorder such as inflammatory bowel disease. The method of the invention includes the step of determining the level of one or more 6-mercaptopurine metabolites in the patient having an immune-mediated gastrointestinal disorder.
    Type: Application
    Filed: April 8, 1999
    Publication date: July 5, 2001
    Applicant: HOPITAL SAINTE-JUSTINE
    Inventors: ERNEST G. SEIDMAN, YVES THEORET